Showing results (251-260 of 272) with videos related to
Sort By:
Pageof 28
The Lancet. Neurology|January 25, 2025
Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trialAli A Habib, Chongbo Zhao, Inmaculada Aban, et al.Journal of Cancer Research and Clinical Oncology|October 12, 2012
A two-SNP IL-6 promoter haplotype is associated with increased lung cancer riskJun Chen, Reng-Yun Liu, Lixin Yang, et al.Eclinicalmedicine|July 18, 2019
Sickle cell trait and risk of cognitive impairment in African-Americans: The REGARDS cohortChristina R Cahill, Justin M Leach, Leslie A McClure, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|March 3, 2022
Perioperative assessment of muscle inflammation susceptibility in patients with end-stage osteoarthritisDevin J Drummer, Jeremy S McAdam, Regina Seay, et al.BMC Genomics|February 13, 2010
Mapping main, epistatic and sex-specific QTL for body composition in a chicken population divergently selected for low or high growth rateGeorgina A Ankra-Badu, Daniel Shriner, Elisabeth Le Bihan-Duval, et al.JACC. Basic to Translational Science|March 7, 2020
Reduced Left Atrial Emptying Fraction and Chymase Activation in Pathophysiology of Primary Mitral RegurgitationBrittany Butts, Mustafa I Ahmed, Navkaranbir S Bajaj, et al.Molecular Cancer Research : MCR|April 19, 2014
Transcriptomes and shRNA suppressors in a TP53 allele-specific model of early-onset colon cancer in African AmericansCharles C Weige, Marc R Birtwistle, Himel Mallick, et al.JCI Insight|March 9, 2018
Exosomal microRNA predicts and protects against severe bronchopulmonary dysplasia in extremely premature infantsCharitharth Vivek Lal, Nelida Olave, Colm Travers, et al.Obesity Science & Practice|October 14, 2022
Mother-child cardiometabolic health 4-10 years after pregnancy complicated by obesity with and without gestational diabetesSamantha L Martin, Li Zhang, Makenzie L Callahan, et al.The Journal of Pediatrics|February 3, 2024
Oral Valganciclovir Initiated Beyond 1 Month of Age as Treatment of Sensorineural Hearing Loss Caused by Congenital Cytomegalovirus Infection: A Randomized Clinical TrialDavid W Kimberlin, Inmaculada Aban, Kalyani Peri, et al.Pageof 28